Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies
NCT ID: NCT04731012
Last Updated: 2021-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2020-01-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy oocyte-donation pregnancy
healthy pregnancy
No interventions assigned to this group
preeclamptic oocyte-donation pregnancy
preeclampsia
No interventions assigned to this group
healthy IVF or ICSI pregnancy
healthy pregnancy
No interventions assigned to this group
preeclamptic IVF or ICSI pregnancy
preeclampsia
No interventions assigned to this group
healthy spontaneous conception pregnancy
healthy pregnancy
No interventions assigned to this group
preeclamptic spontaneous conception pregnancy
preeclampsia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Florian Herse
Doctor of Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Experimental and Clinical Research Center (ECRC)
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Florian Herse, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ED-S
Identifier Type: -
Identifier Source: org_study_id